Laura Gaudet

Dr. Laura Gaudet

Faculty of Medicine, Department of Obstetrics and Gynecology, Queen’s University, Kingston, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LGLaura Gaudet
Laura Gaudet
ZFZachary M. Ferraro
Zachary M. Ferraro
SWShi Wu Wen
Shi Wu Wen
MWMark Walker
Mark Walker
Objective. To determine a precise estimate for the contribution of maternal obesity to macrosomia.Data Sources. The search strategy included database searches in 2011 of PubMed, Medline (In-Process & Other Non-Indexed Citations and Ovid Medline, 1950–2011), and EMBASE Classic + EMBASE. Appropriate search terms were used for each database. Reference lists of retrieved articles and review articles were cross-referenced.Methods of Study Selection. All studies that examined the relationship between maternal obesity (BMI ≥30 kg/m2) (pregravid or at 1st prenatal visit) and fetal macrosomia (birth weight ≥4000 g, ≥4500 g, or ≥90th percentile) were considered for inclusion.Tabulation, Integration, and Results. Data regarding the outcomes of interest and study quality were independently extracted by two reviewers. Results from the meta-analysis showed that maternal obesity is associated with fetal overgrowth, defined as birth weight ≥ 4000 g (OR 2.17, 95% CI 1.92, 2.45), birth weight ≥4500 g (OR 2.77,95% CI 2.22, 3.45), and birth weight ≥90% ile for gestational age (OR 2.42, 95% CI 2.16, 2.72).Conclusion. Maternal obesity appears to play a significant role in the development of fetal overgrowth. There is a critical need for effective personal and public health initiatives designed to decrease prepregnancy weight and optimize gestational weight gain.

10 March 2015 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
WCWenhang Chen
Wenhang Chen
JXJing Xue
Jing Xue
LGLaura Gaudet
Laura Gaudet
MWMark Walker
Mark Walker
SWShi Wu Wen
Shi Wu Wen

1 February 2012 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
ZFZachary M. Ferraro
Zachary M. Ferraro
LGLaura Gaudet
Laura Gaudet
KAKristi B. Adamo
Kristi B. Adamo
Pregnancy is a critical period of body weight regulation. Maternal obesity and excessive gestational weight gain have become increasingly common and contribute to poor obstetrical outcomes for mother and baby. Regular participation in physical activity may improve risk profiles in pregnant women. Our objectives were to provide an overview of maternal-fetal exercise physiology, summarize current evidence on the effects of physical activity during pregnancy on maternal-fetal outcomes, and review the most recent clinical practice guidelines. In addition, we summarize the findings in the context of the current obesity epidemic and discuss implications for clinical practice. A literature review was completed in which we queried OVID (Medline), EMBASE, and PSYCHINFO databases with title words "exercise or physical activity" and "pregnancy or gestation" from 1950 to March 1, 2010. A total of 212 articles were selected for review. Care providers should recommend physical activity to most pregnant women (i.e., those without contraindications) and view participation as a safe and beneficial component of a healthy pregnancy. Obstetricians & Gynecologists and Family Physicians. After participating in this CME activity, physicians should be better able to classify the potential impact of physical activity on maternal glycemic control and fetal growth outcomes. Assess maternal lifestyle and provide recommendations on appropriate gestational weight gain, evaluate pregnant women for contraindications to physical activity participation, make individualized recommendations for exercise participation, and educate patients on the merits of physical activity for health benefit.

1 March 2013 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
DEDarine El-Chaar
Darine El-Chaar
SFSara A. Finkelstein
Sara A. Finkelstein
XTXiaowen Tu
Xiaowen Tu
DFDeshayne B. Fell
Deshayne B. Fell
LGLaura Gaudet
Laura Gaudet
MWMark Walker
Mark Walker

1 January 2018 in Medical Clinics of North America
Verified
Journal Article
Closed access
HDHeidi Dutton
Heidi Dutton
SBSarah Borengasser
Sarah Borengasser
LGLaura Gaudet
Laura Gaudet
LBLinda A. Barbour
Linda A. Barbour
EKErin Joanne Keely
Erin Joanne Keely

25 April 2022 in Obesity Reviews
Verified
Journal Article
Open access
NHNicola Heslehurst
Nicola Heslehurst
LNLem Ngongalah
Lem Ngongalah
TBTheophile Bigirumurame
Theophile Bigirumurame
GNGiang Thu Nguyen
Giang Thu Nguyen
AOAdefisayo Odeniyi
Adefisayo Odeniyi
LHLouise Hayes
Louise Hayes
Summary: Maternal obesity increases pregnancy‐related risks. Women with a body mass index (BMI) ≥ 30 kg/m2 are considered to be at risk and should receive additional care, although approximately half will have uncomplicated pregnancies. This systematic review aimed to identify early pregnancy measures of adiposity associated with adverse maternal health outcomes. Searches included six databases, reference lists, citations, and contacting authors. Screening and quality assessment were carried out by two authors independently. Random effects meta‐analysis and narrative synthesis were conducted. Seventy studies were included with a pooled sample of 89,588 women. Meta‐analysis showed significantly increased odds of gestational diabetes mellitus (GDM) with higher waist circumference (WC) categories (1.40, 95% confidence interval [CI] 1.04, 1.88) and per unit increase in WC (1.31, 95% CI 1.03, 1.67). Women with GDM had higher WC than controls (mean difference [MD] 6.18 cm, 95% CI 3.92, 8.44). WC was significantly associated with hypertensive disorders, delivery‐related outcomes, metabolic syndrome, and composite pregnancy outcomes. Waist to hip ratio was significantly associated with GDM, hypertensive disorders, and delivery‐related outcomes. Fat mass, neck circumference, skinfolds, and visceral fat were significantly associated with adverse outcomes, although limited data were available. Our findings identify the need to explore how useful adiposity measures are at predicting risk in pregnancy, compared with BMI, to direct care to women with the greatest need.